Healthcare Global Enterprises Limited Divests BACC Health Care to Inviga Healthcare Fund I
Healthcare Global Enterprises Limited announced the approval of the divestment of its entire equity shareholding in BACC Health Care Private Limited to Inviga Healthcare Fund I and its nominee. The Proposed Transaction, which was approved by the Company's Board of Directors and Audit Committee during a meeting held on May 19, 2026, involves the sale of BACC's shares for a consideration of INR 37,64,44,788.The sale is set to take place under a Share Purchase Agreement (SPA) between Healthcare Global Enterprises Limited, BACC, and the buyer. The transaction was reportedly finalized following a competitive process and is being undertaken on an arm's length basis.
BACC Health Care Private Limited, which is engaged in the business of fertility and reproductive healthcare services, is noted as not being a material subsidiary of the Company and is not a core business activity of Healthcare Global Enterprises Limited.
Financial Structure of the Divestment
The total consideration for the Proposed Transaction is INR 37,64,44,788. This amount will be received in two tranches:| Consideration Type | Amount (INR) | Description |
|---|---|---|
| Date of Closing Consideration | 28,23,33,591 | Initial amount received upon closing. |
| Deferred Consideration | 9,41,11,197 | To be received within 18 months of the SPA signing. |
The buyer, Inviga Healthcare Fund I and its nominee, is controlled by Dr. B.S. Ajaikumar. Dr. B.S. Ajaikumar is identified as the Promoter and Non-Executive Chairman of the Board of Healthcare Global Enterprises Limited and also the Promoter of Inviga Investment Advisors Private Limited, which acts as the Investment Manager of the Fund.
Strategic Alignment and Rationale
The Company stated that the Proposed Transaction is strategically aligned with its broader capital allocation objectives. The divestment is expected to facilitate greater operational focus and business alignment, allowing Healthcare Global Enterprises Limited to reinvest capital into high growth areas and cancer services.For financial context, the revenue and net worth data for BACC Health Care Private Limited (BACC) for the financial year 2025-26 are as follows:
| Metric | BACC Health Care Private Limited (INR Crores) | Percentage of HCG Standalone Metrics |
|---|---|---|
| Revenue From Operations (FY 25-26) | 60.45 | 4.45% |
| Net worth (as at March 31, 2026) | 17.53 | 1.09% |
The completion of the Proposed Transaction is expected within 4-5 weeks from the date of the agreement, subject to the terms outlined in the SPA.
HCG Stock Price Movement
On Tuesday, shares of Healthcare Global Enterprises Limited edged higher, gaining 2.73% to close at ₹646.85. The stock traded on strong volume of 132,428 shares, holding support between ₹632 and ₹653.7 during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.